Skip to content
Recall Observatory FDA recall evidence

Device product

Sekisui Spectrolyse PAI-1, In-Vitro Diagnostic for Quantitative determination of Plasminogen Activator Inhibitor Type- 1 (PAI-1) activity in human plasma. Catalog Number: 101201 For the determination of Plasminogen Activator Inhibitor Type 1 (PAI-1) activity in human plasma. The test is for in Citro diagnostic use.

Z-2431-2012

August 28, 2012

Class II

Product summary

Firm
Sekisui Diagnostics Llc
Event
Event 63016
Status
Terminated
Classification
Class II
Quantity
699 kits
Official record key
device-enforcement:Z-2431-2012

Official wording

Reason: SPECTROLYSE PAI-1 activity assay producing lower than expected absorbance values with "0" standard. This will reduce the slope of the standard curve requiring the user to make more frequent sample dilutions.

Code information: Lot Numbers: 120425 and 120601

Distribution pattern: Nationwide distribution: USA including states of: FL, IN, IL, and WA.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    SPECTROLYSE PAI-1 activity assay producing lower than expected absorbance values with "0" standard. This will reduce the slope of the standard curve requiring the user to make more frequent sample dilutions.